CAPLIPOINT - Technical Analysis with Chart Patterns & Indicators
Back to ListTechnical Rating: 4.3
| Stock Code | CAPLIPOINT | Market Cap | 12,990 Cr. | Current Price | 1,709 ₹ | High / Low | 2,397 ₹ |
| Stock P/E | 35.9 | Book Value | 243 ₹ | Dividend Yield | 0.35 % | ROCE | 28.6 % |
| ROE | 22.0 % | Face Value | 2.00 ₹ | DMA 50 | 1,707 ₹ | DMA 200 | 1,843 ₹ |
| Chg in FII Hold | -0.43 % | Chg in DII Hold | 0.09 % | PAT Qtr | 87.3 Cr. | PAT Prev Qtr | 103 Cr. |
| RSI | 51.2 | MACD | 21.8 | Volume | 59,539 | Avg Vol 1Wk | 68,815 |
| Low price | 1,500 ₹ | High price | 2,397 ₹ | PEG Ratio | 1.63 | Debt to equity | 0.00 |
| 52w Index | 23.3 % | Qtr Profit Var | 16.8 % | EPS | 47.7 ₹ | Industry PE | 30.1 |
📊 CAPLIPOINT is trading at ₹1,709, right at its 50 DMA (₹1,707) but below its 200 DMA (₹1,843), indicating medium-term resistance overhead. RSI at 51.2 shows neutral momentum, while MACD at 21.8 reflects a bullish crossover. Bollinger Bands suggest price stabilizing near the mid-range. Volume (59,539) is below the weekly average (68,815), showing weaker participation. Overall, the stock is consolidating with a bullish bias.
💡 Optimal Entry Zone: ₹1,690–1,710 (near 50 DMA support).
📈 Exit Zone: ₹1,950–2,000 (trendline resistance) and extended target ₹2,350–2,397 (52-week high).
🔎 Trend Status: Consolidating with upward bias; breakout possible if volume strengthens above average.
✅ Positive
- Strong ROCE of 28.6% and ROE of 22% highlight operational efficiency.
- Debt-free balance sheet (Debt-to-equity 0.00) reduces financial risk.
- EPS of ₹47.7 supports valuation strength.
- MACD crossover signals bullish momentum.
⚠️ Limitation
- High P/E of 35.9 compared to industry PE of 30.1 suggests overvaluation.
- Quarterly PAT declined from ₹103 Cr. to ₹87.3 Cr., showing earnings pressure.
- FII holdings decreased (-0.43%), indicating reduced foreign investor confidence.
- PEG ratio of 1.63 suggests limited growth-adjusted valuation appeal.
📉 Company Negative News
- Recent quarterly profit decline raises concerns about near-term earnings stability.
📈 Company Positive News
- Strong historical ROCE and ROE metrics continue to attract long-term investors.
- DII holdings increased (+0.09%), showing domestic institutional support.
🏭 Industry
- Industry PE at 30.1 is lower than CAPLIPOINT’s 35.9, suggesting relative overvaluation.
- Pharmaceutical sector remains supported by demand for specialty formulations and exports.
🔎 Conclusion
CAPLIPOINT is consolidating near its 50 DMA with bullish signals from MACD but facing resistance at the 200 DMA. Entry near ₹1,690–1,710 offers a favorable setup, while exits near ₹1,950–2,000 or extended targets at ₹2,350–2,397 are prudent. Long-term investors benefit from debt-free status and strong ROCE, but short-term traders should watch for earnings pressure and volume confirmation.